Skip to content
Menu

Acurx Pharmaceuticals Q3 EPS $(0.49) Misses $(0.39) Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.39) by 25.64 percent. This is a 60.16 percent increase over losses of $(1.23) per

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.39) by 25.64 percent. This is a 60.16 percent increase over losses of $(1.23) per share from the same period last year.

Read at benzinga.com